JNJ CIK: 200406

Johnson & Johnson

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
55.3
FY22:
55.4
FY23:
58.6
FY24:
61.4
FY25:
63.9
(positive)
Change from FY21 to FY25
billions USD
FY21:
35.2
FY22:
35.1
FY23:
23.4
FY24:
36.6
FY25:
40.2
(positive)
billions USD
FY21:
–
FY22:
–
FY23:
32.3
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
billions USD
FY21:
19.2
FY22:
19.4
FY23:
15.1
FY24:
16.7
FY25:
32.6
(positive)
Change from FY21 to FY25
billions USD
FY21:
20.9
FY22:
17.9
FY23:
35.2
FY24:
14.1
FY25:
26.8

All amounts in billions USD Data sources:SEC EDGARTwelve Data